PA
Perceptive Advisors’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,360,858
| Closed | -$10.9M | – | 83 |
|
|
2025
Q1 | $10.9M | Hold |
5,360,858
| – | – | 0.38% | 50 |
|
|
2024
Q4 | $32.3M | Hold |
5,360,858
| – | – | 0.89% | 31 |
|
|
2024
Q3 | $37.5M | Hold |
5,360,858
| – | – | 0.79% | 33 |
|
|
2024
Q2 | $31.1M | Buy |
5,360,858
+2,353,000
| +78% | +$13.6M | 0.75% | 38 |
|
|
2024
Q1 | $21.5M | Hold |
3,007,858
| – | – | 0.38% | 60 |
|
|
2023
Q4 | $14.8M | Hold |
3,007,858
| – | – | 0.33% | 57 |
|
|
2023
Q3 | $28.8M | Hold |
3,007,858
| – | – | 0.96% | 33 |
|
|
2023
Q2 | $39M | Hold |
3,007,858
| – | – | 1.13% | 30 |
|
|
2023
Q1 | $38.2M | Hold |
3,007,858
| – | – | 1.13% | 27 |
|
|
2022
Q4 | $34.7M | Buy |
+3,007,858
| New | +$34.7M | 0.97% | 31 |
|